Posted on November 5, 2018 by Chermaen Lindberg
New York, NY (November 5, 2018)—GlycoMark, Inc., the exclusive provider of the GlycoMark® test, is launching live educational support for healthcare professionals through its website, https://glycomark.com/, as part of National Diabetes Month. The new complimentary educational support will offer a live chat and video option via the website in November from 9 a.m. – 5…
Read More
The GlycoMark test is an FDA-cleared, non-fasting serum or plasma test for monitoring blood glucose variability in people with diabetes. The GlycoMark test provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes.